Streptococcus pyogenes biofilms-formation, biology, and clinical relevance
- PMID: 25717441
- PMCID: PMC4324238
- DOI: 10.3389/fcimb.2015.00015
Streptococcus pyogenes biofilms-formation, biology, and clinical relevance
Abstract
Streptococcus pyogenes (group A streptococci, GAS) is an exclusive human bacterial pathogen. The virulence potential of this species is tremendous. Interactions with humans range from asymptomatic carriage over mild and superficial infections of skin and mucosal membranes up to systemic purulent toxic-invasive disease manifestations. Particularly the latter are a severe threat for predisposed patients and lead to significant death tolls worldwide. This places GAS among the most important Gram-positive bacterial pathogens. Many recent reviews have highlighted the GAS repertoire of virulence factors, regulators and regulatory circuits/networks that enable GAS to colonize the host and to deal with all levels of the host immune defense. This covers in vitro and in vivo studies, including animal infection studies based on mice and more relevant, macaque monkeys. It is now appreciated that GAS, like many other bacterial species, do not necessarily exclusively live in a planktonic lifestyle. GAS is capable of microcolony and biofilm formation on host cells and tissues. We are now beginning to understand that this feature significantly contributes to GAS pathogenesis. In this review we will discuss the current knowledge on GAS biofilm formation, the biofilm-phenotype associated virulence factors, regulatory aspects of biofilm formation, the clinical relevance, and finally contemporary treatment regimens and future treatment options.
Keywords: S. pyogenes; antibiotic resistance; biofilm; transcriptional regulation; virulence factors.
Figures
Similar articles
-
Streptococcus pyogenes Capsule Promotes Microcolony-Independent Biofilm Formation.J Bacteriol. 2019 Aug 22;201(18):e00052-19. doi: 10.1128/JB.00052-19. Print 2019 Sep 15. J Bacteriol. 2019. PMID: 31085695 Free PMC article.
-
Streptococcus pyogenes adhesion and colonization.FEBS Lett. 2016 Nov;590(21):3739-3757. doi: 10.1002/1873-3468.12254. Epub 2016 Jul 1. FEBS Lett. 2016. PMID: 27312939 Review.
-
Evolutionary Constraints Shaping Streptococcus pyogenes-Host Interactions.Trends Microbiol. 2017 Jul;25(7):562-572. doi: 10.1016/j.tim.2017.01.007. Epub 2017 Feb 16. Trends Microbiol. 2017. PMID: 28216292 Free PMC article. Review.
-
Copper Tolerance and Characterization of a Copper-Responsive Operon, copYAZ, in an M1T1 Clinical Strain of Streptococcus pyogenes.J Bacteriol. 2015 Aug 1;197(15):2580-92. doi: 10.1128/JB.00127-15. Epub 2015 May 26. J Bacteriol. 2015. PMID: 26013489 Free PMC article.
-
Fukugiside, a biflavonoid from Garcinia travancorica inhibits biofilm formation of Streptococcus pyogenes and its associated virulence factors.J Med Microbiol. 2018 Sep;67(9):1391-1401. doi: 10.1099/jmm.0.000799. Epub 2018 Jul 27. J Med Microbiol. 2018. PMID: 30052177
Cited by
-
Dihydrothiazolo ring-fused 2-pyridone antimicrobial compounds treat Streptococcus pyogenes skin and soft tissue infection.bioRxiv [Preprint]. 2024 Jan 3:2024.01.02.573960. doi: 10.1101/2024.01.02.573960. bioRxiv. 2024. PMID: 38260261 Free PMC article. Preprint.
-
Antimicrobial and wound healing potential of naphthoquinones encapsulated in nanochitosan.Front Bioeng Biotechnol. 2024 Jan 4;11:1284630. doi: 10.3389/fbioe.2023.1284630. eCollection 2023. Front Bioeng Biotechnol. 2024. PMID: 38239922 Free PMC article.
-
A Case of Severe Mpox Complicated with Streptococcus pyogenes Sepsis in a Patient with HIV Infection.Pathogens. 2023 Aug 23;12(9):1073. doi: 10.3390/pathogens12091073. Pathogens. 2023. PMID: 37764881 Free PMC article.
-
The Anti-Biofilm Potential of Linalool, a Major Compound from Hedychium larsenii, against Streptococcus pyogenes and Its Toxicity Assessment in Danio rerio.Antibiotics (Basel). 2023 Mar 9;12(3):545. doi: 10.3390/antibiotics12030545. Antibiotics (Basel). 2023. PMID: 36978412 Free PMC article.
-
trans-Cinnamaldehyde as a Novel Candidate to Overcome Bacterial Resistance: An Overview of In Vitro Studies.Antibiotics (Basel). 2023 Jan 27;12(2):254. doi: 10.3390/antibiotics12020254. Antibiotics (Basel). 2023. PMID: 36830165 Free PMC article. Review.
References
-
- Ardanuy C., Domenech A., Rolo D., Calatayud L., Tubau F., Ayats J., et al. . (2010). Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008). J. Antimicrob. Chemother. 65, 634–643. 10.1093/jac/dkq006 - DOI - PubMed
-
- Baldassarri L., Creti R., Recchia S., Imperi M., Facinelli B., Giovanetti E., et al. . (2006). Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation. J. Clin. Microbiol. 44, 2721–2727. 10.1128/JCM.00512-06 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
